Jordan Park

Jordan Park

Healthcare & Biotech Analyst

Healthcare and biotech analyst focused on pharma pipelines, medtech adoption curves, and reimbursement dynamics. Former clinical research coordinator and later equity research analyst. Writes thesis-driven pieces that connect clinical catalysts, competitive landscapes, and valuation scenarios.

Articles 769

Nathan Chasing Horse Found Guilty of Multiple Sexual Assault Charges
Jan 30, 2026 News & Politics

Nathan Chasing Horse Found Guilty of Multiple Sexual Assault Charges

Actor Convicted in Las Vegas Trial Centering on Abuse of Indigenous Women and Girls

Nathan Chasing Horse, known for his role in "Dances With Wolves," was convicted by a Nevada jury of 13 sexual assault charges involving Indigenous vic...

Jan 30, 2026 Trade Ideas

Paysafe: Navigating the Deleveraging Tightrope - A Tactical Long with a Tight Stop

High risk, asymmetric reward if management can prove deleveraging and legal overhangs clear

Paysafe (PSFE) is a beaten-up payments platform trading near multi-month lows after earnings misses, a business disposal and a series of securities in...

Trade Idea Long
SoFi Launches Up to $1,000 in Free Stock to Attract New Investors
Jan 30, 2026 Business News

SoFi Launches Up to $1,000 in Free Stock to Attract New Investors

Innovative Offering Aims to Lower Entry Barriers for Self-Directed Investing with Zero Commissions and Fractional Shares

SoFi is currently providing a promotional opportunity for new investors opening a self-directed account, granting up to $1,000 worth of free stock. Th...

Jan 30, 2026 Finance

Riot Platforms Shares Decline Amid Bitcoin Volatility and Strategic Shifts

Cryptocurrency price fluctuations and new AI infrastructure investments influence Riot Platforms' stock performance

Riot Platforms experienced a significant drop in its stock price during Friday trading, driven primarily by the recent decrease in Bitcoin's value. Th...

Jan 30, 2026 Finance

ResMed Posts Strong Q2 Earnings, Analysts Uphold Positive Growth Outlook Despite Market Challenges

Company's innovative AI-driven therapy device gains FDA clearance as sales and margins improve; industry analysts remain cautiously optimistic amid competitive concerns

ResMed Inc reported better-than-expected financial results for its second fiscal quarter of 2026, highlighted by robust sales growth and enhanced gros...

Understanding Negative Net Worth Among Americans and Strategies for Financial Stability
Jan 30, 2026 Business News

Understanding Negative Net Worth Among Americans and Strategies for Financial Stability

Examining the impact of debt on net worth and practical methods to maintain positive financial health

A significant portion of American households experience negative net worth due to high debt levels outpacing their assets. This analysis explores how ...

Shaquille O'Neal Details Divergent Approaches in Raising Sons and Daughters
Jan 30, 2026 Business News

Shaquille O'Neal Details Divergent Approaches in Raising Sons and Daughters

The NBA Hall of Famer shares distinct expectations he holds for his children’s paths to adulthood and independence

Shaquille O'Neal, renowned NBA Hall of Famer and entrepreneur, has openly discussed the contrasting parenting strategies he employs for his three sons...

Jan 30, 2026 Finance

DraftKings Shares Decline Following Regulatory Policy Shift on Prediction Markets

Guggenheim trims price target as CFTC signals support for clearer rules in prediction markets

Shares of DraftKings Inc. experienced a notable decline amid a backdrop of regulatory changes and revised analyst price targets. The Commodity Futures...

Jan 30, 2026 Finance

Regeneron Faces Decline in Eylea Sales Amid Market Challenges, Commits $2 Billion to New Manufacturing Expansion

Despite a 3% increase in overall revenue, Regeneron’s flagship eye treatment sees significant sales drop as company invests heavily in production capacity.

Regeneron Pharmaceuticals reported a slight year-over-year increase in total revenue but experienced a notable decline in net sales for its leading op...

Jan 30, 2026 Finance

LyondellBasell Posts Mixed Fourth-Quarter 2025 Results While Emphasizing Robust Cash Positions and Enhanced Cost Efficiency

Despite Revenue Beats, Adjusted Earnings Fall Short as Petrochemical Market Pressures Persist

LyondellBasell Industries revealed its financial performance for the fourth quarter of 2025, where revenues surpassed analyst projections but adjusted...